BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27380341)

  • 1. Lynch Syndrome Testing: A Missed Opportunity in the Era of Precision Medicine.
    Pasche B; Pennison MJ; DeYoung B
    JAMA; 2016 Jul; 316(1):38-9. PubMed ID: 27380341
    [No Abstract]   [Full Text] [Related]  

  • 2. The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates.
    Grosse SD; Palomaki GE; Mvundura M; Hampel H
    Genet Med; 2015 Jun; 17(6):510-1. PubMed ID: 26035801
    [No Abstract]   [Full Text] [Related]  

  • 3. One size may not fit all: the debate of universal tumor testing for Lynch syndrome.
    Lu KH; Ring KL
    Gynecol Oncol; 2015 Apr; 137(1):2-3. PubMed ID: 25818039
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
    Usha L; Dewdney SB; Buckingham LE
    JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347
    [No Abstract]   [Full Text] [Related]  

  • 5. A Practical Approach to the Evaluation of Gastrointestinal Tract Carcinomas for Lynch Syndrome.
    Pai RK; Pai RK
    Am J Surg Pathol; 2016 Apr; 40(4):e17-34. PubMed ID: 26974895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonoscopy and chromoscopy in hereditary colorectal cancer syndromes.
    Jenkins Wessling E; Lanspa SJ
    Fam Cancer; 2016 Jul; 15(3):453-5. PubMed ID: 26892866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counseling and cascade genetic testing in Lynch syndrome.
    Hampel H
    Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
    Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
    Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lynch syndrome.
    Backes FJ; Cohn DE
    Clin Obstet Gynecol; 2011 Jun; 54(2):199-214. PubMed ID: 21508689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family matters in lynch syndrome.
    Kastrinos F; Steyerberg EW
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794515
    [No Abstract]   [Full Text] [Related]  

  • 11. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
    Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
    Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of screening strategies for Lynch syndrome.
    Barzi A; Sadeghi S; Kattan MW; Meropol NJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.
    Vasen HF; Velthuizen ME; Kleibeuker JH; Menko FH; Nagengast FM; Cats A; van der Meulen-de Jong AE; Breuning MH; Roukema AJ; van Leeuwen-Cornelisse I; de Vos Tot Nederveen Cappel WH; Wijnen JT
    Fam Cancer; 2016 Jul; 15(3):429-35. PubMed ID: 26973060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up recommendations and risk-reduction initiatives for Lynch syndrome.
    Guillén-Ponce C; Molina-Garrido MJ; Carrato A
    Expert Rev Anticancer Ther; 2012 Oct; 12(10):1359-67. PubMed ID: 23176623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal testing of cutaneous sebaceous carcinoma: a missed opportunity in Lynch syndrome detection.
    Rajan N; Cook S; Best K; ; Monahan K
    Lancet Oncol; 2024 Jan; 25(1):e1-e2. PubMed ID: 38181808
    [No Abstract]   [Full Text] [Related]  

  • 17. Ready, get set, go: Fast preoperative genetic diagnosis is the present future in Lynch syndrome surgical strategy.
    Piozzi GN; Ricci MT; Signoroni S; Vitellaro M
    Dig Liver Dis; 2019 Dec; 51(12):1742-1743. PubMed ID: 31678042
    [No Abstract]   [Full Text] [Related]  

  • 18. Lynch Syndrome Screening in the Gynecologic Tract: Current State of the Art.
    Mills AM; Longacre TA
    Am J Surg Pathol; 2016 Apr; 40(4):e35-44. PubMed ID: 26872009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "scope" of colorectal cancer screening in Lynch syndrome: is there an optimal interval?
    Biller LH; Ng K
    J Natl Cancer Inst; 2023 Jul; 115(7):775-777. PubMed ID: 37140568
    [No Abstract]   [Full Text] [Related]  

  • 20. Hereditary Colorectal Cancer: Genetics and Screening.
    Brosens LA; Offerhaus GJ; Giardiello FM
    Surg Clin North Am; 2015 Oct; 95(5):1067-80. PubMed ID: 26315524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.